Journey Medical Corporation Common Stock DERM
HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERICi
Market datapartial · fetched 2026-11-13T02:13:17.026Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T23:02:27.398277978Z
FundamentalsAlpha Vantage · ready · quarter 2026-06-30 · fetched 2026-11-13T02:08:16.277601+00:00
Journey Medical Corporation Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 6.90 | 305.5% | 64.2% | |||
| 25Δ | 6.56 | 333.2% | 60.2% | |||
| 30Δ | 6.23 | 361.0% | 56.3% | |||
| 35Δ | 5.89 | 388.7% | 52.3% | |||
| 40Δ | 5.56 | 416.4% | 48.3% | |||
| 45Δ | 5.23 | 444.1% | 44.4% | |||
| 50Δ | 4.89 | 471.9% | 40.4% | |||
| 55Δ | 4.56 | 499.6% | 36.4% | |||
| 60Δ | 4.22 | 527.3% | 32.5% | |||
| 65Δ | 3.89 | 555.1% | 28.5% | |||
| 70Δ | 3.56 | 582.8% | 24.5% | |||
| 75Δ | 3.22 | 610.5% | 20.6% | |||
| 80Δ | 2.89 | 638.2% | 16.6% | |||
20Δ
- Pseudo strike
- 6.90
- IV
- 305.5%
- B/E move
- 64.2%
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- 6.56
- IV
- 333.2%
- B/E move
- 60.2%
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- 6.23
- IV
- 361.0%
- B/E move
- 56.3%
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- 5.89
- IV
- 388.7%
- B/E move
- 52.3%
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- 5.56
- IV
- 416.4%
- B/E move
- 48.3%
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- 5.23
- IV
- 444.1%
- B/E move
- 44.4%
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- 4.89
- IV
- 471.9%
- B/E move
- 40.4%
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- 4.56
- IV
- 499.6%
- B/E move
- 36.4%
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- 4.22
- IV
- 527.3%
- B/E move
- 32.5%
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- 3.89
- IV
- 555.1%
- B/E move
- 28.5%
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- 3.56
- IV
- 582.8%
- B/E move
- 24.5%
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- 3.22
- IV
- 610.5%
- B/E move
- 20.6%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 2.89
- IV
- 638.2%
- B/E move
- 16.6%
- Pseudo strike
- IV
- B/E move
Options history
No recorded observations
Drug Manufacturers - Specialty & Generic
EBS
Emergent BioSolutions Inc., a life sciences company, focuses on providing preparedness and response products and solutions for civilian and military populations that address…
More →ELAN
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures and markets products for pets and farm animals. The company is headquartered in…
More →EOLS
Evolus, Inc., a high-performance beauty company, provides aesthetic medical products for physicians and their patients in the United States. The company is headquartered in…
More →ETON
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and marketing pharmaceuticals for rare diseases. The company is headquartered in Deer Park,…
More →GLAS
Description unavailable
More →HCM
HUTCHMED (China) Limited discovers, develops and markets targeted immunotherapies and therapies for cancer and immune diseases globally. The company is headquartered in Central,…
More →